Skip to main content
. 2018 Oct 16;9(81):35251–35265. doi: 10.18632/oncotarget.25834

Table 5a. FDG-PET responses in patients receiving upfront SRT (29 patients).

FDG-PET response
CMR PMR SMD PMD
Sites of disease
 Lung 11 1 7 2 1
 Liver 7 2 4 0 1
 Lung and liver 5 0 2 1 2
 Presence of LN metastases 6 1 1 2 1